Health in an Obama world: what we know so far

We know the name of the 44th President of the United States: Barack Obama. As the next President’s supporter Oprah Winfrey is known to ask, “What do you know for sure?” When it comes to health, there are a few things we know about a President Obama.First and foremost, addressing challenges in U.S. health care […]

Read full story Comments { 0 }

A statistical profile of the US on election day 2008; and freebies, galore!

Go get your treats today while you make your way to the polls: Starbucks is offering free coffee, Dunkin‘ Donuts has star-shaped cakes, and Ben & Jerry’s will offer free scoops between 5 and 8 pm. While you’re enjoying some sweet stuff, ponder some important statistics on this Election Day 2008….    Toyota will probably be […]

Read full story Comments { 0 }

Pre-Election Day, Health Looms Heavy on American Voters' Minds — but McCain Voters' Priorities Are Strikingly Different Than Obama Supporters

While the economy ranks as the #1 issue on American voters’ minds, it means way more to Obama voters (56%) than it does to McCain voters (40%).Health care, too, is a higher priority issue to Obama voters (14%) than to McCain voters (9%).The poll by Kaiser Family Foundation and Harvard School of Public Health, conducted […]

Read full story Comments { 0 }

Prices, inefficiency, and paperwork: the 3 key cost drivers of U.S. health care

The three reasons why health spending is higher in the U.S. than in any other country are: prices, inefficiency, and insurance administration. Medical technology and obesity are key cost drivers. Malpractice costs and demographic shifts are not (these add to overall costs but not as significantly to cost increases as tech, obesity, prices, inefficiency, and […]

Read full story Comments { 0 }

Very slow growth forcast for pharma in U.S. in 2009

The U.S. pharmaceutical market is slow-growth for 2009, according to IMS Health. The company forecasts a tiny 1-2% growth rate for the next year. The data point comes from IMS’s annual Global Pharmaceutical and Therapy Forecast.   The U.S. market for pharmaceuticals will be worth about $300 bn in 2009.   What’s slowing growth prospects […]

Read full story Comments { 0 }